Biomarin Pharmaceutical (BM8.STU) Q1 2026 Earnings

23FebConfirmed
Q1 2026
-0.2
-0.09
0.03
0.14

Details

Expected EPS
0.14369102855000002
Actual EPS
-0.203556
Surprise EPS
-0.35
Surprise Percent
+241.66%

Description

Biomarin Pharmaceutical (BM8.STU) has reported earnings of -0.203556 per share for Q1 2026.

0 Comments

Share your thoughts